Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immature and misleading

12.04.2012
Are modern molecular classification methods for breast carcinomas reasonable?

Austrian scientists challenge the clinical relevance of the term “basal-like” breast cancer subtype. Not all breast cancers are the same. Different types can mean different prognoses for the patient, and a different kind of treatment may be adequate. But how to classify tumors? Are molecular classification methods reliable?

Mohammad Ali Lavasani and Farid Moinfar from the Unit of Breast and Gynecologic Pathology at the Medical University of Graz, Austria give a critical review of the literature with focus on “basal-like” carcinoma.

The conventional clinicopathological parameters such as histologic grade, nuclear grade, tumor size, involvement of axillary lymph nodes, etc., all have been successfully correlated to prognosis of patients with breast carcinoma. Yet, the current prognostic and/or predictive factors have significant limitations in distinguishing breast cancer patients who could benefit from (neo)adjuvant chemotherapy from those who do not need any additional treatment.

Indeed, it has been suggested that almost 70% of patients with breast cancer receiving chemotherapy or antihormonal therapy would have survived without such treatments, as Lavasani and Moinfar state in their review.

With the introduction of complementary DNA (cDNA) and oligonucleotide microarrays in the 1990s, the increasing application of these high-throughput biotechnologies, and significant improvement in bioinformatic analyses a new era began: Genome-wide approaches were used to prognostify and predict outcome in patients with breast cancer. During the last 11 years, 5 molecular subtypes of breast carcinoma (luminal A, luminal B, Her2-positive, basal-like, and normal breast-like) have been characterized and intensively studied. As genomic research evolves, further subtypes of breast cancers into new “molecular entities” are expected to occur. For example, a new and rare breast cancer subtype, known as claudin-low, has been recently found.

“There is no doubt that global gene expression analyses using high-throughput biotechnologies have drastically improved our understanding of breast cancer as a heterogeneous disease”, say Lavasani and Moinfar. “The main question is, however, whether new molecular techniques such as gene expression profiling (or signature) should be regarded as the gold standard for identifying breast cancer subtypes.” When reviewing the literature, the two scientists discovered major problems with current molecular techniques and classification including poor definitions, lack of reproducibility, and lack of quality control. They conclude: “The current molecular approaches cannot be incorporated into routine clinical practice and treatment decision making as they are immature or even can be misleading.”

The “basal-like” breast cancer subtype represents one of the most popular breast cancer “entities”. However, the authors revealed some major problems and misconceptions with and about this subtype and denote the term “basal-like” as misleading. They come to the conclusion that there is no evidence that expression of basal-type cytokeratins in a given breast cancer, regardless of other established prognostic factors, does have any impact on clinical outcome. Lavasani and Moinfar are convinced that these so-called basal-like carcinomas do not reflect a single, biologically uniform group of breast cancers. Indeed, they show significant variations in their phenotypes, grades, immunoprofiles, and clinical outcomes. (Text by K. Maedefessel-Herrmann)

M. A. Lavasani and F. Moinfar, J. Biophotonics 5(4), 345-366 (2012); http://dx.doi.org/10.1002/jbio.201100097

Journal of Biophotonics publishes cutting edge research on interactions between light and biological material. The journal is highly interdisciplinary, covering research in the fields of life sciences, medicine, physics, chemistry, and enginieering. The scope extends from basic research to clinical applications. Connecting scientists who try to understand basic biological processes using light as a diagnostic and therapeutic tool, the journal offers a platform where the physicist communicates with the biologist and where the clinical practitioner learns about the latest tools for diagnosis of diseases. JBP offers fast publication times: down to 20 days from acceptance to publication. Latest Journal Impact Factor (2010): 4.240 (ISI Journal Citation Reports 2010)

Regina Hagen
Journal Publishing Manager | Editorial Physics Department
Wiley-VCH Verlag GmbH & Co. KGaA
Rotherstr. 21, 10245 Berlin, Germany
Fon: +49 (0) 30/ 47 03 13 21
Fax: +49 (0) 30/ 47 03 13 99
E-Mail: regina.hagen@wiley.com

Lavasani and F. Moinfar | Wiley-VCH
Further information:
http://dx.doi.org/10.1002/jbio.201100097
http://www.wiley.com

More articles from Life Sciences:

nachricht Exciting Plant Vacuoles
14.06.2019 | Julius-Maximilians-Universität Würzburg

nachricht A microscopic topographic map of cellular function
13.06.2019 | University of Missouri-Columbia

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: MPSD team discovers light-induced ferroelectricity in strontium titanate

Light can be used not only to measure materials’ properties, but also to change them. Especially interesting are those cases in which the function of a material can be modified, such as its ability to conduct electricity or to store information in its magnetic state. A team led by Andrea Cavalleri from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg used terahertz frequency light pulses to transform a non-ferroelectric material into a ferroelectric one.

Ferroelectricity is a state in which the constituent lattice “looks” in one specific direction, forming a macroscopic electrical polarisation. The ability to...

Im Focus: Determining the Earth’s gravity field more accurately than ever before

Researchers at TU Graz calculate the most accurate gravity field determination of the Earth using 1.16 billion satellite measurements. This yields valuable knowledge for climate research.

The Earth’s gravity fluctuates from place to place. Geodesists use this phenomenon to observe geodynamic and climatological processes. Using...

Im Focus: Tube anemone has the largest animal mitochondrial genome ever sequenced

Discovery by Brazilian and US researchers could change the classification of two species, which appear more akin to jellyfish than was thought.

The tube anemone Isarachnanthus nocturnus is only 15 cm long but has the largest mitochondrial genome of any animal sequenced to date, with 80,923 base pairs....

Im Focus: Tiny light box opens new doors into the nanoworld

Researchers at Chalmers University of Technology, Sweden, have discovered a completely new way of capturing, amplifying and linking light to matter at the nanolevel. Using a tiny box, built from stacked atomically thin material, they have succeeded in creating a type of feedback loop in which light and matter become one. The discovery, which was recently published in Nature Nanotechnology, opens up new possibilities in the world of nanophotonics.

Photonics is concerned with various means of using light. Fibre-optic communication is an example of photonics, as is the technology behind photodetectors and...

Im Focus: Cost-effective and individualized advanced electronic packaging in small batches now available

Fraunhofer IZM is joining the EUROPRACTICE IC Service platform. Together, the partners are making fan-out wafer level packaging (FOWLP) for electronic devices available and affordable even in small batches – and thus of interest to research institutes, universities, and SMEs. Costs can be significantly reduced by up to ten customers implementing individual fan-out wafer level packaging for their ICs or other components on a multi-project wafer. The target group includes any organization that does not produce in large quantities, but requires prototypes.

Research always means trying things out and daring to do new things. Research institutes, universities, and SMEs do not produce in large batches, but rather...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

Concert of magnetic moments

14.06.2019 | Information Technology

Materials informatics reveals new class of super-hard alloys

14.06.2019 | Materials Sciences

New imaging modality targets cholesterol in arterial plaque

14.06.2019 | Medical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>